SCHEMBL22189183

SCHEMBL22189183

c1ccc(Nc2c3c(cc(-c4ccccc4)c2-c2ccccc2)-c2ccccc2C3)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 2/20 0.42
KDR P35968 3/20 0.40
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
CASP6 P55212 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
CNR1 P21554 1/20 0.35
SRD5A2 P31213 1/20 0.35
CYP1A2 P05177 3/20 0.35
ADRA2A P08913 1/20 0.35
MAOA P21397 1/20 0.35
SLC6A2 P23975 1/20 0.35
HTR2C P28335 1/20 0.35
SLC6A4 P31645 1/20 0.35
HTR2B P41595 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CYP3A4 P08684 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30021723 1.00 PDGFRB (0.42) PDGFRBKDRMEN1MAPTKMT2A
SCHEMBL22157558 0.93 KDR (0.38) PDGFRBKDRMAPTADORA2AADORA1
SCHEMBL30302886 0.93 KDR (0.38) PDGFRBKDRMAPTADORA2AADORA1
SCHEMBL30021758 0.81 RAPGEF4 (0.43) MEN1MAPTKMT2ACYP1A2ADRA2A
SCHEMBL22189188 0.81 CHRNB2 (0.41) MEN1KMT2AADORA2AADORA1NPC1
SCHEMBL30302652 0.81 CHRNB2 (0.41) MEN1KMT2AADORA2AADORA1NPC1
SCHEMBL29730452 0.80 KDR (0.41) KDRMAPTADORA2AADORA1SRD5A2
SCHEMBL28230767 0.80 KDR (0.41) KDRMAPTADORA2AADORA1SRD5A2
SCHEMBL30021673 0.79 NPC1 (0.34) PDGFRBKDRMEN1MAPTKMT2A
SCHEMBL30302882 0.77 KDR (0.40) KDRMAPTADORA2AADORA1SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12590249-B2 Etchant composition SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-03-31 US claimed
US-20220025261-A1 ETCHANT COMPOSITION SOULBRAIN CO., LTD. (KR) 2022-01-27 US claimed
US-12590249-B2 Etchant composition SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-03-31 US disclosed
US-20220025261-A1 ETCHANT COMPOSITION SOULBRAIN CO., LTD. (KR) 2022-01-27 US disclosed
US-11142694-B2 Etchant composition and method of fabricating semiconductor device SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-10-12 US disclosed
US-20200216758-A1 ETCHANT COMPOSITION AND METHOD OF FABRICATING SEMICONDUCTOR DEVICE SOULBRAIN CO., LTD. (KR) 2020-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12590249-B2 Etchant composition ASIC1, NOS1, CA1 PDGFRB 2549/4885KDR 1807/4885MEN1 2066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.